Literature DB >> 9131556

Relationship between clinical signs of upper respiratory tract disease and antibodies to Mycoplasma agassizii in desert tortoises from Nevada.

I M Schumacher1, D B Hardenbrook, M B Brown, E R Jacobson, P A Klein.   

Abstract

Plasma samples collected in 1990 from free-ranging desert tortoises (Gopherus agassizii) with and without clinical signs of upper respiratory tract disease (URTD) from Las Vegas Valley, Clark County, Nevada (USA), were tested by enzyme-linked immunosorbent assay (ELISA) for antibodies to Mycoplasma agassizii, a causative agent of URTD. The relationship between clinical signs and ELISA test results was evaluated. Of the 144 tortoises tested, 45 (31%) had clinical signs while 72 (50%) were seropositive. Presence of clinical signs of URTD was positively related to positive ELISA results (P < 0.0001) regardless of sex or age of the animal. Eighty-four percent of animals with clinical signs tested seropositive. Mucous nasal discharge, the most severe and obvious of the clinical signs, was highly predictive for exposure to M. agassizii based on the ELISA. Ninety-three percent of tortoises with mucous nasal discharge tested seropositive. Serologic testing for M. agassizii antibodies supported clinical signs as useful indicators of URTD, but it also detected potential subclinical infection in 34 (34%) of 99 animals without clinical signs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131556     DOI: 10.7589/0090-3558-33.2.261

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  6 in total

1.  Mycoplasma agassizii strain variation and distinct host antibody responses explain differences between enzyme-linked immunosorbent assays and Western blot assays.

Authors:  Lori D Wendland; Paul A Klein; Elliott R Jacobson; Mary B Brown
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

2.  Upper respiratory tract disease in the gopher tortoise is caused by Mycoplasma agassizii.

Authors:  M B Brown; G S McLaughlin; P A Klein; B C Crenshaw; I M Schumacher; D R Brown; E R Jacobson
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

3.  Improved enzyme-linked immunosorbent assay to reveal Mycoplasma agassizii exposure: a valuable tool in the management of environmentally sensitive tortoise populations.

Authors:  Lori D Wendland; Laurie A Zacher; Paul A Klein; Daniel R Brown; Dina Demcovitz; Ramon Littell; Mary B Brown
Journal:  Clin Vaccine Immunol       Date:  2007-07-11

4.  Co-infection does not predict disease signs in Gopherus tortoises.

Authors:  Chava L Weitzman; Ryan Gov; Franziska C Sandmeier; Sarah J Snyder; C Richard Tracy
Journal:  R Soc Open Sci       Date:  2017-10-18       Impact factor: 2.963

5.  Host species, pathogens and disease associated with divergent nasal microbial communities in tortoises.

Authors:  Chava L Weitzman; Franziska C Sandmeier; C Richard Tracy
Journal:  R Soc Open Sci       Date:  2018-10-10       Impact factor: 2.963

6.  Comprehensive health assessment and blood analyte reference intervals of gopher tortoises (Gopherus polyphemus) in southeastern FL, USA.

Authors:  Annie Page-Karjian; Kathleen Rafferty; Clerson Xavier; Nicole I Stacy; Jon A Moore; Sarah E Hirsch; Samantha Clark; Charles A Manire; Justin R Perrault
Journal:  Conserv Physiol       Date:  2021-03-26       Impact factor: 3.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.